Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
Clinical trial NCT06351150 · RECRUITING
Trial details
- NCT number
- NCT06351150
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-23
- Primary completion
- 2027-06-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.